Test Bank For Rau's Respiratory Care Pharmacology 11th Edition
Chapter 1. Introduction to Respiratory Care Pharmacology
Chapter 1. Introduction to Respiratory Care Pharmacology
1. The listing of a drug and the amount of drug are found in which part of a prescription?
a) Superscription
*b) Inscription
c) Subscription
d) Transcription
General Feedback:
The superscription directs the pharmacist to take the drug listed and prepare
the medication; the inscription lists the name and quantity of the drug being prescribed;
the subscription provides directions to the pharmacist for preparing the medication; and
the transcription, or signature, is the information the pharmacist writes on the label as
instructions to the patient.
Feedback:
*b) The superscription directs the pharmacist to take the drug listed and
prepare the medication; the inscription lists the name and quantity of the drug being
prescribed; the subscription provides directions to the pharmacist for preparing the
medication; and the transcription, or signature, is the information the pharmacist writes
on the label as instructions to the patient.
2. If generic substitution is permitted on a prescription
a) drug from only one manufacturer must be given.
b) drug formulation may be changed by the pharmacist.
*c) any manufactured brand of the drug listed may be given.
d) drug strength may be changed by the pharmacist.
General Feedback:
A generic substitution allows any brand of a drug to be given, but the
pharmacist may not change a drug formulation without specific permission from the
prescribing physician. A physician can indicate to the pharmacist that generic substitution
is permitted in the filling of the prescription. In such a case, the pharmacist may provide
any manufacturer’s version of the prescribed drug, rather than a specific brand. However,
the pharmacist may not change the strength of a drug without specific permission from
the prescribing physician.
Feedback:
*c) A generic substitution allows any brand of a drug to be given, but the
pharmacist may not change a drug formulation without specific permission from the
prescribing physician. A physician can indicate to the pharmacist that generic substitution
is permitted in the filling of the prescription. In such a case, the pharmacist may provide
,Test Bank For Rau's Respiratory Care Pharmacology 11th Edition
Chapter 1. Introduction to Respiratory Care Pharmacology
any manufacturer’s version of the prescribed drug, rather than a specific brand. However,
the pharmacist may not change the strength of a drug without specific permission from
the prescribing physician.
3. The study of drugs, including their origin, properties, and interactions with living
organisms, is known as
a) pharmacogenetics.
*b) pharmacology.
c) therapeutics.
d) toxicology.
General Feedback:
Pharmacogenetics is the study of the interrelationship of genetic differences
and drug effects. Pharmacology is the study of drugs (chemicals), including their origin,
properties, and interactions with living organisms. Therapeutics is the art of treating
disease with drugs. Toxicology is the study of toxic substances and their pharmacologic
actions, including antidotes and poison control.
Feedback:
*b) Pharmacogenetics is the study of the interrelationship of genetic
differences and drug effects. Pharmacology is the study of drugs (chemicals), including
their origin, properties, and interactions with living organisms. Therapeutics is the art of
treating disease with drugs. Toxicology is the study of toxic substances and their
pharmacologic actions, including antidotes and poison control.
4. The brand name given to a drug by a particular manufacturer is known as the drug’s
a) chemical name.
b) generic name.
c) official name.
*d) trade name.
General Feedback:
The chemical name indicates the drug’s chemical structure. The generic name
is assigned by the U.S. Adopted Name Council and is usually based loosely on the drug’s
chemical structure. The official name is the name given to the generic name once a drug
becomes fully approved for general use and is admitted to the U.S. Pharmacopeia–
National Formulary. The trade name is the brand, or proprietary, name given by a
particular manufacturer. For example, the generic drug albuterol is currently marketed by
Schering-Plough as Proventil® and by GlaxoSmithKline as Ventolin®.
Feedback:
*d) The chemical name indicates the drug’s chemical structure. The generic
name is assigned by the U.S. Adopted Name Council and is usually based loosely on the
,Test Bank For Rau's Respiratory Care Pharmacology 11th Edition
Chapter 1. Introduction to Respiratory Care Pharmacology
drug’s chemical structure. The official name is the name given to the generic name once a
drug becomes fully approved for general use and is admitted to the U.S. Pharmacopeia–
National Formulary. The trade name is the brand, or proprietary, name given by a
particular manufacturer. For example, the generic drug albuterol is currently marketed by
Schering-Plough as Proventil® and by GlaxoSmithKline as Ventolin®.
5. To find official information about drugs (according to the FDA), you need to go to the
a) Physician’s Desk Reference (PDR).
b) Basic & Clinical Pharmacology.
*c) U.S. Pharmacopeia-National Formulary (USP-NF).
d) Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
General Feedback:
Because the PDR is prepared by drug manufacturers themselves, it may be
lacking in objectivity. Basic & Clinical Pharmacology covers only general pharmacologic
principles and drug classes. Goodman & Gilman’s The Pharmacological Basis of
Therapeutics covers only general pharmacologic principles and drug classes. The USP-
NF is a book of standards containing information about medications, dietary
supplements, and medical devices. The U.S. Food and Drug Administration (FDA)
considers this book the official standard for drugs marketed in the United States.
Feedback:
*c) Because the PDR is prepared by drug manufacturers themselves, it may
be lacking in objectivity. Basic & Clinical Pharmacology covers only general
pharmacologic principles and drug classes. Goodman & Gilman’s The Pharmacological
Basis of Therapeutics covers only general pharmacologic principles and drug classes. The
USP-NF is a book of standards containing information about medications, dietary
supplements, and medical devices. The U.S. Food and Drug Administration (FDA)
considers this book the official standard for drugs marketed in the United States.
6. Drugs may be obtained from which of the following sources?
a) Plants
b) Animals
c) Minerals
*d) Plants, animals, and minerals
General Feedback:
Drugs may be obtained from plants (e.g., digitalis), animals (e.g., insulin),
and minerals (e.g., magnesium sulfate).
Feedback:
*d) Drugs may be obtained from plants (e.g., digitalis), animals (e.g.,
insulin), and minerals (e.g., magnesium sulfate).
, Test Bank For Rau's Respiratory Care Pharmacology 11th Edition
Chapter 1. Introduction to Respiratory Care Pharmacology
7. The branch of the U.S. government responsible for the process of approving drugs for
clinical use is the
a) USAN Council.
*b) FDA.
c) USP-NF.
d) PDR.
General Feedback:
The U.S. Adopted Name (USAN) Council is responsible for assigning a
generic name to a chemical that appears to have therapeutic use. The U.S. Food and Drug
Administration (FDA) is responsible for the process of approving drugs for clinical use.
The process by which a chemical moves from the status of a promising potential drug to
one fully approved by the FDA for general clinical use is, on average, long, costly, and
complex. The USP-NF is a book of standards for medications, dietary supplements, and
medical devices. The PDR is a source of drug information prepared by drug
manufacturers.
Feedback:
*b) The U.S. Adopted Name (USAN) Council is responsible for assigning a
generic name to a chemical that appears to have therapeutic use. The U.S. Food and Drug
Administration (FDA) is responsible for the process of approving drugs for clinical use.
The process by which a chemical moves from the status of a promising potential drug to
one fully approved by the FDA for general clinical use is, on average, long, costly, and
complex. The USP-NF is a book of standards for medications, dietary supplements, and
medical devices. The PDR is a source of drug information prepared by drug
manufacturers.
8. An orphan drug is a drug that is
*a) used for rare disease.
b) used for common disease.
c) inexpensive to produce.
d) not claimed by a drug manufacturer.
General Feedback:
An orphan drug is a drug or biologic product for the diagnosis or treatment of
a rare disease. Rare is defined as a disease that affects less than 200,000 persons in the
United States. Alternatively, a drug may be designated as an orphan if used for a disease
that affects more than 200,000 persons in the United States but for which there is no
reasonable expectation of recovering the cost of drug development. Orphan drugs are
often quite expensive to produce because they have a limited market in which to recoup
the initial investment.
Chapter 1. Introduction to Respiratory Care Pharmacology
Chapter 1. Introduction to Respiratory Care Pharmacology
1. The listing of a drug and the amount of drug are found in which part of a prescription?
a) Superscription
*b) Inscription
c) Subscription
d) Transcription
General Feedback:
The superscription directs the pharmacist to take the drug listed and prepare
the medication; the inscription lists the name and quantity of the drug being prescribed;
the subscription provides directions to the pharmacist for preparing the medication; and
the transcription, or signature, is the information the pharmacist writes on the label as
instructions to the patient.
Feedback:
*b) The superscription directs the pharmacist to take the drug listed and
prepare the medication; the inscription lists the name and quantity of the drug being
prescribed; the subscription provides directions to the pharmacist for preparing the
medication; and the transcription, or signature, is the information the pharmacist writes
on the label as instructions to the patient.
2. If generic substitution is permitted on a prescription
a) drug from only one manufacturer must be given.
b) drug formulation may be changed by the pharmacist.
*c) any manufactured brand of the drug listed may be given.
d) drug strength may be changed by the pharmacist.
General Feedback:
A generic substitution allows any brand of a drug to be given, but the
pharmacist may not change a drug formulation without specific permission from the
prescribing physician. A physician can indicate to the pharmacist that generic substitution
is permitted in the filling of the prescription. In such a case, the pharmacist may provide
any manufacturer’s version of the prescribed drug, rather than a specific brand. However,
the pharmacist may not change the strength of a drug without specific permission from
the prescribing physician.
Feedback:
*c) A generic substitution allows any brand of a drug to be given, but the
pharmacist may not change a drug formulation without specific permission from the
prescribing physician. A physician can indicate to the pharmacist that generic substitution
is permitted in the filling of the prescription. In such a case, the pharmacist may provide
,Test Bank For Rau's Respiratory Care Pharmacology 11th Edition
Chapter 1. Introduction to Respiratory Care Pharmacology
any manufacturer’s version of the prescribed drug, rather than a specific brand. However,
the pharmacist may not change the strength of a drug without specific permission from
the prescribing physician.
3. The study of drugs, including their origin, properties, and interactions with living
organisms, is known as
a) pharmacogenetics.
*b) pharmacology.
c) therapeutics.
d) toxicology.
General Feedback:
Pharmacogenetics is the study of the interrelationship of genetic differences
and drug effects. Pharmacology is the study of drugs (chemicals), including their origin,
properties, and interactions with living organisms. Therapeutics is the art of treating
disease with drugs. Toxicology is the study of toxic substances and their pharmacologic
actions, including antidotes and poison control.
Feedback:
*b) Pharmacogenetics is the study of the interrelationship of genetic
differences and drug effects. Pharmacology is the study of drugs (chemicals), including
their origin, properties, and interactions with living organisms. Therapeutics is the art of
treating disease with drugs. Toxicology is the study of toxic substances and their
pharmacologic actions, including antidotes and poison control.
4. The brand name given to a drug by a particular manufacturer is known as the drug’s
a) chemical name.
b) generic name.
c) official name.
*d) trade name.
General Feedback:
The chemical name indicates the drug’s chemical structure. The generic name
is assigned by the U.S. Adopted Name Council and is usually based loosely on the drug’s
chemical structure. The official name is the name given to the generic name once a drug
becomes fully approved for general use and is admitted to the U.S. Pharmacopeia–
National Formulary. The trade name is the brand, or proprietary, name given by a
particular manufacturer. For example, the generic drug albuterol is currently marketed by
Schering-Plough as Proventil® and by GlaxoSmithKline as Ventolin®.
Feedback:
*d) The chemical name indicates the drug’s chemical structure. The generic
name is assigned by the U.S. Adopted Name Council and is usually based loosely on the
,Test Bank For Rau's Respiratory Care Pharmacology 11th Edition
Chapter 1. Introduction to Respiratory Care Pharmacology
drug’s chemical structure. The official name is the name given to the generic name once a
drug becomes fully approved for general use and is admitted to the U.S. Pharmacopeia–
National Formulary. The trade name is the brand, or proprietary, name given by a
particular manufacturer. For example, the generic drug albuterol is currently marketed by
Schering-Plough as Proventil® and by GlaxoSmithKline as Ventolin®.
5. To find official information about drugs (according to the FDA), you need to go to the
a) Physician’s Desk Reference (PDR).
b) Basic & Clinical Pharmacology.
*c) U.S. Pharmacopeia-National Formulary (USP-NF).
d) Goodman & Gilman’s The Pharmacological Basis of Therapeutics.
General Feedback:
Because the PDR is prepared by drug manufacturers themselves, it may be
lacking in objectivity. Basic & Clinical Pharmacology covers only general pharmacologic
principles and drug classes. Goodman & Gilman’s The Pharmacological Basis of
Therapeutics covers only general pharmacologic principles and drug classes. The USP-
NF is a book of standards containing information about medications, dietary
supplements, and medical devices. The U.S. Food and Drug Administration (FDA)
considers this book the official standard for drugs marketed in the United States.
Feedback:
*c) Because the PDR is prepared by drug manufacturers themselves, it may
be lacking in objectivity. Basic & Clinical Pharmacology covers only general
pharmacologic principles and drug classes. Goodman & Gilman’s The Pharmacological
Basis of Therapeutics covers only general pharmacologic principles and drug classes. The
USP-NF is a book of standards containing information about medications, dietary
supplements, and medical devices. The U.S. Food and Drug Administration (FDA)
considers this book the official standard for drugs marketed in the United States.
6. Drugs may be obtained from which of the following sources?
a) Plants
b) Animals
c) Minerals
*d) Plants, animals, and minerals
General Feedback:
Drugs may be obtained from plants (e.g., digitalis), animals (e.g., insulin),
and minerals (e.g., magnesium sulfate).
Feedback:
*d) Drugs may be obtained from plants (e.g., digitalis), animals (e.g.,
insulin), and minerals (e.g., magnesium sulfate).
, Test Bank For Rau's Respiratory Care Pharmacology 11th Edition
Chapter 1. Introduction to Respiratory Care Pharmacology
7. The branch of the U.S. government responsible for the process of approving drugs for
clinical use is the
a) USAN Council.
*b) FDA.
c) USP-NF.
d) PDR.
General Feedback:
The U.S. Adopted Name (USAN) Council is responsible for assigning a
generic name to a chemical that appears to have therapeutic use. The U.S. Food and Drug
Administration (FDA) is responsible for the process of approving drugs for clinical use.
The process by which a chemical moves from the status of a promising potential drug to
one fully approved by the FDA for general clinical use is, on average, long, costly, and
complex. The USP-NF is a book of standards for medications, dietary supplements, and
medical devices. The PDR is a source of drug information prepared by drug
manufacturers.
Feedback:
*b) The U.S. Adopted Name (USAN) Council is responsible for assigning a
generic name to a chemical that appears to have therapeutic use. The U.S. Food and Drug
Administration (FDA) is responsible for the process of approving drugs for clinical use.
The process by which a chemical moves from the status of a promising potential drug to
one fully approved by the FDA for general clinical use is, on average, long, costly, and
complex. The USP-NF is a book of standards for medications, dietary supplements, and
medical devices. The PDR is a source of drug information prepared by drug
manufacturers.
8. An orphan drug is a drug that is
*a) used for rare disease.
b) used for common disease.
c) inexpensive to produce.
d) not claimed by a drug manufacturer.
General Feedback:
An orphan drug is a drug or biologic product for the diagnosis or treatment of
a rare disease. Rare is defined as a disease that affects less than 200,000 persons in the
United States. Alternatively, a drug may be designated as an orphan if used for a disease
that affects more than 200,000 persons in the United States but for which there is no
reasonable expectation of recovering the cost of drug development. Orphan drugs are
often quite expensive to produce because they have a limited market in which to recoup
the initial investment.
